Organogenesis Holdings Inc. to Participate in the Truist Securities MedTech Conference
06 Junio 2024 - 3:05PM
Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative
medicine company focused on the development, manufacture, and
commercialization of product solutions for the Advanced Wound Care
and Surgical & Sports Medicine markets, today announced that
management will participate in the Truist Securities MedTech
Conference, which is being held at the InterContinental Boston in
Boston, MA on Tuesday, June 18th. Management will participate in
1x1 meetings. There will be no formal presentation.
About Organogenesis Holdings Inc.
Organogenesis Holdings Inc. is a leading
regenerative medicine company focused on the development,
manufacture, and commercialization of solutions for the advanced
wound care and surgical and sports medicine markets. Organogenesis
offers a comprehensive portfolio of innovative regenerative
products to address patient needs across the continuum of care. For
more information, visit www.organogenesis.com.
Investor Inquiries:
ICR Westwicke
Mike Piccinino, CFA
OrganoIR@westwicke.com
Press and Media Inquiries:
Organogenesis
communications@organo.com
Organogenesis (NASDAQ:ORGO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Organogenesis (NASDAQ:ORGO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024